Effectiveness of matching human leukocyte antigens
Effectiveness of matching human leukocyte antigens (HLA) in corneal transplantation: a scientific overview protocol
Background: Corneal transplantation is probably the most steadily carried out transplantation within the UK. Regardless of this, the therapeutic worth of matching human leukocyte antigen (HLA) subtypes for transplanted corneas stays controversial. Ocular immune privilege was initially deemed to render matching pointless; nevertheless, extra lately, matching has demonstrated improved outcomes together with graft success, amongst others. This systematic overview goals to guage the effectiveness of main and minor antigen matching on graft outcomes in corneal transplantation.
Strategies: Normal systematic overview methodology can be used to determine, choose and extract knowledge from observational research and medical trials assessing the results of HLA matching on corneal graft outcomes. Bibliographic databases (Cochrane Library, EMBASE, MEDLINE, Net of Science, Scopus), medical trial registers, summary and convention proceedings, along with dissertation, thesis and gray literature can be searched. Neither date of publication nor language can be restricted, and non-English articles can be translated the place obligatory. The first end result can be to evaluate corneal graft success for various levels of HLA matching/mismatching.
The exact finish end result measure varies amongst research and contains graft rejection, immunoreaction, failure and survival. Subsequently, knowledge can be extracted throughout all related end result parameters and grouped for subsequent statistical exams. Danger of bias evaluation can be accomplished, acceptable to every examine design. Research choice, knowledge extraction and threat of bias evaluation can be independently accomplished by two reviewers. Knowledge can be tabulated, and a story synthesis introduced. Meta-analysis can be carried out the place there may be ample homogeneity between research to warrant its efficient completion. Subgroup and sensitivity evaluation can be undertaken if acceptable.
Dialogue: Many research have investigated the effectiveness of HLA matching for corneal transplantation. A scientific overview is required to collate and analyse this proof. Findings of this systematic overview might kind the premise of evidence-based suggestions on pre-operative HLA typing and matching of corneal grafts for transplantation.
Rat Anti SCL 70 antibody ELISA kit |
|||
| E02S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Anti SCL 70 antibody ELISA kit |
|||
| E02S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rat Anti SCL 70 antibody ELISA kit |
|||
| E02S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Anti SCL 70 antibody ELISA kit |
|||
| E07S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Anti SCL 70 antibody ELISA kit |
|||
| E07S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Pig Anti SCL 70 antibody ELISA kit |
|||
| E07S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Anti SCL 70 antibody ELISA kit |
|||
| E08S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Anti SCL 70 antibody ELISA kit |
|||
| E08S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Dog Anti SCL 70 antibody ELISA kit |
|||
| E08S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Anti SCL 70 antibody ELISA kit |
|||
| E06S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Anti SCL 70 antibody ELISA kit |
|||
| E06S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Goat Anti SCL 70 antibody ELISA kit |
|||
| E06S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Anti SCL 70 antibody ELISA kit |
|||
| E03S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Anti SCL 70 antibody ELISA kit |
|||
| E03S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Anti SCL 70 antibody ELISA kit |
|||
| E03S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Anti SCL 70 antibody ELISA kit |
|||
| E01S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Anti SCL 70 antibody ELISA kit |
|||
| E01S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Human Anti SCL 70 antibody ELISA kit |
|||
| E01S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Anti SCL 70 antibody ELISA kit |
|||
| E04S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Anti SCL 70 antibody ELISA kit |
|||
| E04S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Anti SCL 70 antibody ELISA kit |
|||
| E04S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Anti SCL 70 antibody ELISA kit |
|||
| E09S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Anti SCL 70 antibody ELISA kit |
|||
| E09S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Monkey Anti SCL 70 antibody ELISA kit |
|||
| E09S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
DNA Topoisomerase I (TOP1, Scl-70) Antibody |
|||
| 30267-05111 | AssayPro | 150 ug | EUR 313.2 |
Rat Scl-70 Ab ELISA Kit |
|||
| ERS0249 | Abclonal | 96Tests | EUR 625.2 |
Goat Scl-70 Ab ELISA Kit |
|||
| EGTS0249 | Abclonal | 96Tests | EUR 625.2 |
Mouse Scl-70 Ab ELISA Kit |
|||
| EMS0249 | Abclonal | 96Tests | EUR 625.2 |
Human Scl-70 Ab ELISA Kit |
|||
| EHS0249 | Abclonal | 96Tests | EUR 625.2 |
Rabbit Scl-70 Ab ELISA Kit |
|||
| ERTS0249 | Abclonal | 96Tests | EUR 625.2 |
Bovine Scl-70 Ab ELISA Kit |
|||
| EBS0249 | Abclonal | 96Tests | EUR 625.2 |
Canine Scl-70 Ab ELISA Kit |
|||
| ECS0249 | Abclonal | 96Tests | EUR 625.2 |
Porcine Scl-70 Ab ELISA Kit |
|||
| EPS0249 | Abclonal | 96Tests | EUR 625.2 |
Anserini Scl-70 Ab ELISA Kit |
|||
| EAS0249 | Abclonal | 96Tests | EUR 625.2 |
Guinea pig Anti SCL 70 antibody ELISA kit |
|||
| E05S0243-192T | BlueGene | 192 tests | EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Anti SCL 70 antibody ELISA kit |
|||
| E05S0243-48 | BlueGene | 1 plate of 48 wells | EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea pig Anti SCL 70 antibody ELISA kit |
|||
| E05S0243-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig Anti SCL 70 antibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Guinea Pig Scl-70 Ab ELISA Kit |
|||
| EGS0249 | Abclonal | 96Tests | EUR 625.2 |
DNA Topoisomerase I (TOP1, Scl-70) Antibody (Biotin Conjugate) |
|||
| 30267-05121 | AssayPro | 150 ug | EUR 442.8 |
DNA Topoisomerase I (TOP1, Scl-70) AssayLite Antibody (RPE Conjugate) |
|||
| 30267-05151 | AssayPro | 150 ug | EUR 513.6 |
DNA Topoisomerase I (TOP1, Scl-70) AssayLite Antibody (APC Conjugate) |
|||
| 30267-05161 | AssayPro | 150 ug | EUR 513.6 |
DNA Topoisomerase I (TOP1, Scl-70) AssayLite Antibody (FITC Conjugate) |
|||
| 30267-05141 | AssayPro | 150 ug | EUR 513.6 |
DNA Topoisomerase I (TOP1, Scl-70) AssayLite Antibody (PerCP Conjugate) |
|||
| 30267-05171 | AssayPro | 150 ug | EUR 565.2 |
Mouse Anti-Hepatitis B Core Antigen (a.a. 70-80) Monoclonal Antibody |
|||
| DMAB3506 | Creative Diagnostics | 0.1 mg | EUR 826.8 |
Recombinant (sf9) Human Scl-70 protein (>95%, His-tag) |
|||
| SCL702-R-10 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Human Scl-70 Autoantibody IgG ELISA Kit (Direct EIA) |
|||
| EK7087 | BosterBio | 96wells/kit, with removable strips. | EUR 573.6 |
Recombinant (sf9) Human Scl-70 protein WB +ve control |
|||
| SCL701-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Recombinant Plasmodium Falciparum PPF2L antigen Protein (aa 1-70) |
|||
| VAng-Wyb6754-1mgBaculovirus | Creative Biolabs | 1 mg (Baculovirus) | EUR 8391.6 |
|
Description: Plasmodium Falciparum (isolate Palo Alto / Uganda) PPF2L antigen, recombinant protein. |
|||
Recombinant Plasmodium Falciparum PPF2L antigen Protein (aa 1-70) |
|||
| VAng-Wyb6754-500gBaculovirus | Creative Biolabs | 500 µg (Baculovirus) | EUR 5388 |
|
Description: Plasmodium Falciparum (isolate Palo Alto / Uganda) PPF2L antigen, recombinant protein. |
|||
Recombinant Plasmodium Falciparum PPF2L antigen Protein (aa 1-70) |
|||
| VAng-Wyb6754-50gBaculovirus | Creative Biolabs | 50 µg (Baculovirus) | EUR 2881.2 |
|
Description: Plasmodium Falciparum (isolate Palo Alto / Uganda) PPF2L antigen, recombinant protein. |
|||
Cancer Antigen 242 Antigen |
|||
| VAng-Cr3876-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration. |
|||
Mouse Anti-Hepatitis C Virus Core Antigen (a.a. 70-90) Monoclonal Antibody |
|||
| DMAB3561 | Creative Diagnostics | 0.1 mg | EUR 937.2 |
Cancer Antigen 50 Antigen |
|||
| VAng-Cr3877-50kU | Creative Biolabs | 50 kU | EUR 6642 |
|
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Cancer Antigen 72-4 Antigen |
|||
| VAng-Cr3878-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Human Anti-Scl-70 (Scl70/Scleroderma 70 Kda/DNA-topoisomerase-1) IgG negative control serum/plasma |
|||
| 3300-140-N01 | Alpha Diagnostics | 1 ml | EUR 196.8 |
Human Anti-Scl-70 (Scl70/Scleroderma 70 Kda/DNA-topoisomerase-1) IgG positive control serum/plasma |
|||
| 3300-140-P02 | Alpha Diagnostics | 1 ml | EUR 270 |
Human Anti-Scl-70 (Scl70/Scleroderma 70 Kda/DNA-topoisomerase-1) IgG ELISA kit, 96 tests, Quantitative |
|||
| 3300-140-SCG | Alpha Diagnostics | 1 Kit | EUR 708 |
Cancer Antigen 125 Antigen (Ascites Fluid) |
|||
| VAng-Cr3870-10kU | Creative Biolabs | 10 kU | EUR 1132.8 |
|
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE. |
|||
Cancer Antigen 125 Antigen (Human Adenocarcinoma) |
|||
| VAng-Cr3868-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography. |
|||
Human carcinoembryonic antigen (CEA) antigen |
|||
| CEA15-N-100 | Alpha Diagnostics | 100 ug | EUR 270 |
Cancer Antigen CEA Antigen (Human Fluids) |
|||
| VAng-Wyb8644-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL. |
|||
Cancer Antigen 19-9 Antigen (Liver Carcinoma) |
|||
| VAng-Cr3873-10kU | Creative Biolabs | 10 kU | EUR 472.8 |
|
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Prostate Specific Antigen Std Grade Antigen |
|||
| VAng-Cr3891-1mg | Creative Biolabs | 1 mg | EUR 604.8 |
|
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation. |
|||
Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%) |
|||
| VAng-Cr3869-25kU | Creative Biolabs | 25 kU | EUR 967.2 |
|
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186. |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00123-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00123-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00124-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
|||
HBV surface recombinant antigen HBsAg antigen |
|||
| 00124-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
|||
Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) |
|||
| VAng-Cr3875-25kU | Creative Biolabs | 25 kU | EUR 885.6 |
|
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
Positive Control Set (SS-A, SS-B, Sm, RNP, Scl-70, Jo-1) Antibody |
|||
| abx022694-1Set | Abbexa | 1 Set | EUR 1696.8 |
Cancer Antigen AFP Antigen (Human Cord Blood) |
|||
| VAng-Wyb8624-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL. |
|||
Cancer Antigen CA-125 Antigen (Human Fluids) |
|||
| VAng-Wyb8639-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CA-125, Calibrator Grade, cancer antigen from Human Fluids, 53.26 KU/mL. |
|||
Cancer Antigen 15-3 MUC 1 Antigen (Human Milk) |
|||
| VAng-Cr3871-10kU | Creative Biolabs | 10 kU | EUR 505.2 |
|
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
|||
MPO Antigen |
|||
| E61A00501 | EnoGene | 1mg | EUR 1230 |
HAV Antigen |
|||
| E61H00101 | EnoGene | 1mg | EUR 733.2 |
HBS Antigen |
|||
| E61H00301 | EnoGene | 1mg | EUR 374.4 |
HBS Antigen |
|||
| E61H00302 | EnoGene | 1mg | EUR 374.4 |
HBe Antigen |
|||
| E61H00501 | EnoGene | 1mg | EUR 463.2 |
HBc Antigen |
|||
| E61H00701 | EnoGene | 1mg | EUR 463.2 |
AFP Antigen |
|||
| E62C002 | EnoGene | 20ug | EUR 458.4 |
HCG Antigen |
|||
| E62C004 | EnoGene | 100ug | EUR 458.4 |
CEA Antigen |
|||
| E62C010 | EnoGene | 20ug | EUR 458.4 |
CK8 Antigen |
|||
| E62C02001 | EnoGene | 20ug | EUR 458.4 |
CRP Antigen |
|||
| E64C00501 | EnoGene | 1mg | EUR 840 |
CRP Antigen |
|||
| E64C00502 | EnoGene | 1mg | EUR 840 |
CD9 Antigen |
|||
| E6TA00101 | EnoGene | 0.1mg | EUR 411.6 |
BSA Antigen |
|||
| IM112 | Cygnus Technologies | 1 ml | EUR 342 |
|
Description: BSA Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
HSA Antigen |
|||
| IM118 | Cygnus Technologies | 1 ml | EUR 342 |
|
Description: HSA Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
CDV Antigen |
|||
| VAng-Lsx0016-1mg | Creative Biolabs | 1 mg | EUR 1688.4 |
|
Description: Canine Distemper Virus Antigen from SL-29 cells. |
|||
Gastrointestinal Cancer Antigen (CA 19-9), antigen grade |
|||
| CA1991-N-10 | Alpha Diagnostics | 10 KU | EUR 634.8 |
S100 Antigen |
|||
| E62B003 | EnoGene | 20ug | EUR 458.4 |
CA50 Antigen |
|||
| E62C009 | EnoGene | 10KU | EUR 458.4 |
CK18 Antigen |
|||
| E62C02101 | EnoGene | 20ug | EUR 458.4 |
CK20 Antigen |
|||
| E62C02201 | EnoGene | 20ug | EUR 458.4 |
GP73 antigen |
|||
| E62C02701 | EnoGene | 20ug | EUR 458.4 |
TP17 Antigen |
|||
| E62H00701 | EnoGene | 100ug | EUR 458.4 |
TP47 Antigen |
|||
| E62H00702 | EnoGene | 100ug | EUR 458.4 |
cTnI antigen |
|||
| E64C00101 | EnoGene | 100ug | EUR 508.8 |
cTnI antigen |
|||
| E64C00102 | EnoGene | 100ug | EUR 733.2 |
cTnC antigen |
|||
| E64C01301a | EnoGene | 20ug | EUR 411.6 |
sST2 antigen |
|||
| E64C01501 | EnoGene | 20ug | EUR 411.6 |
PAPP Antigen |
|||
| E64D00101 | EnoGene | 100ug | EUR 1425.6 |
PAPP Antigen |
|||
| E64D00102 | EnoGene | 1mg | EUR 5910 |
CD63 Antigen |
|||
| E6TA00102 | EnoGene | 0.1mg | EUR 411.6 |
CD81 Antigen |
|||
| E6TA00103 | EnoGene | 0.1mg | EUR 411.6 |
Cancer Antigen CEA Antigen (Human Metastatic Liver) |
|||
| VAng-Wyb8645-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL. |
|||
CA242 Antigen |
|||
| E62C00601 | EnoGene | 50KU | EUR 2078.4 |
CA242 Antigen |
|||
| E62C00602 | EnoGene | 10KU | EUR 458.4 |
CA199 Antigen |
|||
| E62C007 | EnoGene | 10KU | EUR 458.4 |
CA199 Antigen |
|||
| E62C00701 | EnoGene | 50KU | EUR 1180.8 |
CA199 Antigen |
|||
| E62C00702 | EnoGene | 50KU | EUR 1620 |
CA125 Antigen |
|||
| E62C011 | EnoGene | 10KU | EUR 458.4 |
CA153 Antigen |
|||
| E62C012 | EnoGene | 10KU | EUR 458.4 |
EpCAM Antigen |
|||
| E64B00107 | EnoGene | 0.1mg | EUR 411.6 |
HSP70 Antigen |
|||
| E6TA00104 | EnoGene | 0.1mg | EUR 411.6 |
CD133 Antigen |
|||
| E6TA00105 | EnoGene | 0.1mg | EUR 411.6 |
CD32a Antigen |
|||
| E6TA00106 | EnoGene | 0.1mg | EUR 411.6 |
CA199 Antigen |
|||
| E62C00702-1 | EnoGene | 50KU | EUR 1000 |
Cancer Antigen CA-125 Antigen (Human Adenocarcinoma) |
|||
| VAng-Wyb8642-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL. |
|||
S100BB Antigen |
|||
| E62B00201 | EnoGene | 20ug | EUR 458.4 |
S100BB Antigen |
|||
| E62B00202 | EnoGene | 20ug | EUR 458.4 |
S100A1B Antigen |
|||
| E62B00101 | EnoGene | 20ug | EUR 458.4 |
S100A1B Antigen |
|||
| E62B00102 | EnoGene | 20ug | EUR 458.4 |
Insulin Antigen |
|||
| E64I001 | EnoGene | 1mg | EUR 418.8 |
Insulin Antigen |
|||
| IM121 | Cygnus Technologies | 1 ml | EUR 342 |
|
Description: Insulin Antigen by Cygnus Technologies is available in Europe via Gentaur. |
|||
Giardia Trophozoite Recombinant antigen antigen 34 kDa |
|||
| 00321-V-01mg | Virogen | 0,1 mg | EUR 321 |
|
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 |
|||
Giardia Trophozoite Recombinant antigen antigen 34 kDa |
|||
| 00321-V-1000ug | Virogen | 1000 ug | EUR 1539 |
|
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 |
|||
Cancer Antigen 19-9 Antigen (Liver Carcinoma) (High purity) |
|||
| VAng-Cr3874-25kU | Creative Biolabs | 25 kU | EUR 1033.2 |
|
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. |
|||
Ferritin Antigen |
|||
| E62C013 | EnoGene | 100ug | EUR 458.4 |
Ferritin Antigen |
|||
| E62C01304 | EnoGene | 100ug | EUR 458.4 |
Copeptin antigen |
|||
| E64C01601 | EnoGene | 100ug | EUR 411.6 |
Cancer Antigen AFP Antigen (Human hepatocellular carcinoma) |
|||
| VAng-Wyb8625-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Alpha Fetoprotein, Antigen Grade, Cancer antigen from human hepatocellular carcinoma, 2.93 mg/mL. |
|||
Rotavirus Antigen |
|||
| DAGA-258 | Creative Diagnostics | 1 ml dry ice | EUR 873.6 |
Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid) |
|||
| VAng-Cr3872-10kU | Creative Biolabs | 10 kU | EUR 1363.2 |
|
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid. |
|||
Enterovirus Antigen |
|||
| 30-1984 | Fitzgerald | 1 mg | EUR 855.6 |
|
Description: Enterovirus Protein |
|||
Hydrocodone Antigen |
|||
| VAng-Cr3693-1mg | Creative Biolabs | 1 mg | EUR 967.2 |
|
Description: Hydrocodone Antigen, matched pairs: JP101, JP102 or JP103 (detection); Used for ELISA, Lateral Flow. |
|||
RV Antigen (E1) |
|||
| E61Y00101 | EnoGene | 1mg | EUR 840 |
Calprotectin Antigen |
|||
| DAG-T1230 | Creative Diagnostics | 1mg | EUR 4446 |
SS-A Antigen |
|||
| E61A00301 | EnoGene | 1mg | EUR 1230 |
SS-B Antigen |
|||
| E61A00401 | EnoGene | 1mg | EUR 1230 |
IL-2 antigen |
|||
| E6IE600106 | EnoGene | 20ug | EUR 411.6 |
IL-4 antigen |
|||
| E6IE600107 | EnoGene | 20ug | EUR 411.6 |
IL-6 antigen |
|||
| E6IE600108 | EnoGene | 20ug | EUR 411.6 |
IL-2 antigen |
|||
| E6L00106 | EnoGene | 20ug | EUR 458.4 |
IL-4 antigen |
|||
| E6L00107 | EnoGene | 20ug | EUR 458.4 |
IL-6 antigen |
|||
| E6L00108 | EnoGene | 20ug | EUR 458.4 |
Thyroglobulin Antigen |
|||
| VAng-Cr3893-1mg | Creative Biolabs | 1 mg | EUR 604.8 |
|
Description: Thyroglobulin Antigen, Host/Source: Human Thyroid Tissue. The purity is> 95% by SDS-PAGE. |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNCA0228-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),APC conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC800228-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF680 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC800228-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF680 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC810228-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF680R conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC810228-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF680R conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC940228-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF594 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC940228-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF594 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC700228-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF770 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC700228-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF770 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC880228-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF488A conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC880228-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF488A conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC430228-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF543 conjugate, Concentration: 0.1mg/mL |
|||
HL-60 Antigen / Human Leukemia Antigen (IPO-M6) Antibody |
|||
| BNC430228-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against HL-60 Antigen / Human Leukemia Antigen (IPO-M6),CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD4 + T Cells of Prostate Most cancers Sufferers Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
The adaptive immune response to extreme acute respiratory coronavirus 2 (SARS-CoV-2) is essential for vaccine growth and within the restoration from coronavirus illness 2019 (COVID-19). Males and most cancers sufferers have been reported to be at greater dangers of contracting the virus and creating the extra extreme types of COVID-19. Prostate most cancers (PCa) could also be related to each of those dangers. We present that CD4+ T cells of SARS-CoV-2-unexposed sufferers with hormone-refractory (HR) metastatic PCa had decreased CD4+ T cell immune responses to antigens from SARS-CoV-2 spike glycoprotein however not from the spiked glycoprotein of the ‘frequent chilly’-associated human coronavirus 229E (HCoV-229E) as in contrast with wholesome male volunteers who responded comparably to each HCoV-229E- and SARS-CoV-2-derived antigens.
Furthermore, the HCoV-229E spike glycoprotein antigen-elicited CD4+ T cell immune responses cross-reacted with the SARS-CoV-2 spiked glycoprotein antigens. PCa sufferers might have impaired responses to the vaccination, and the cross-reactivity can mediate antibody-dependent enhancement (ADE) of COVID-19. These findings spotlight the potential for elevated vulnerability of PCa sufferers to COVID-19.
Circulating SARS-CoV-2 Vaccine Antigen Detected within the Plasma of mRNA-1273 Vaccine Recipients
SARS-CoV-2 proteins had been measured in longitudinal plasma samples collected from 13 individuals who obtained two doses of mRNA-1273 vaccine. 11 of 13 individuals confirmed detectable ranges of SARS-CoV-2 protein as early as day one after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with manufacturing of IgG and IgA.
Characterizing Prostate-Particular Antigen Ranges at Dying in Sufferers with Metastatic Castration-Resistant Prostate Most cancers: Are We Underutilizing Imaging?
Background: Prostate-specific antigen (PSA) is a beneficial prognostic and predictive biomarker in prostate most cancers; nevertheless, the importance of PSA at or close to the time of demise isn’t properly understood. This examine aimed to characterize the importance of PSA at demise in sufferers with metastatic castration-resistant prostate most cancers (mCRPC).
Sufferers and strategies: The Mount Sinai Genitourinary Most cancers Biorepository, an institutional overview board-approved, single-institution database containing all consented genitourinary most cancers sufferers seen between 2010 and 2018, was used to determine and stratify sufferers into the next cohorts based mostly on their PSA at or close to demise: <100 ng/mL, 100-1000 ng/mL, and >1000 ng/mL. Analyses had been carried out to evaluate medical traits of illness, remedy response, and outcomes.
Outcomes: We recognized 1097 sufferers with prostate most cancers, and 101 had been confirmed to be deceased following a prognosis of mCRPC. In sufferers with mCRPC, cohorts of upper PSA degree at demise had been related to decrease Gleason rating at prognosis and a pattern towards longer time to mCRPC and longer time from prognosis to demise, regardless of the next burden of illness at demise. Conversely, subgroup evaluation of PSA < 10 ng/mL at demise was related to decrease charges of imaging inside 6 months of demise, decrease remedy charge, and worse medical outcomes.
Conclusions: Cohorts of various PSA ranges at demise in mCRPC sufferers confirmed distinct patterns of illness traits and medical outcomes, possible as a result of underlying molecular phenotype variations. Imaging for the affected person inhabitants with very low PSA ranges could also be underutilized and needs to be thought-about extra routinely.
Actual-world medical efficiency of economic SARS-CoV-2 speedy antigen exams in suspected COVID-19: A scientific meta-analysis of obtainable knowledge as per November 20, 2020
Goals: Speedy antigen exams, or RATs, are a sort of lateral move chromatographic immunoassay which have been utilized to assist prognosis of SARS-CoV-2 an infection. We carried out a scientific meta-analysis to check the real-world efficiency of commercially obtainable RATs.
Strategies: We searched a number of databases and web sites for manufacturer-independent potential medical efficiency research evaluating SARS-CoV-2 RATs and RT-PCR. Solely research on RATs that didn’t want a separate reader for end result retrieval and that reported knowledge on viral load, sufferers’ symptom standing, pattern kind, and PCR assay used had been included.
Outcomes: 19 research using 11,109 samples with 2,509 RT-PCR-positives had been included. RAT sensitivity various between 28.9% (95% CI 16.4-44.3) and 98.3% (95% CI 91.1-99.7), possible dependent upon inhabitants traits, viral load, and symptom standing. RAT specificity various between 92.4% (95% CI 87.4-95.9) and 100% (95% CI 99.7-100) with one outlier. The RATs by Roche Diagnostics/SD Biosensor and Abbott had the very best pooled sensitivity (82.4% [95% CI 74.2-88.4] and 76.9% [95% CI 72.1-81.2], respectively). Sensitivity in high-viral-load samples (cycle threshold ≤25) confirmed heterogeneity among the many totally different RATs.
Conclusion: The RATs provided by Roche Diagnostics/SD Biosensor and Abbott present ample manufacturer-independent, real-world efficiency knowledge to help their use for detection of present SARS-CoV-2 an infection, notably in high-viral-load populations.
